business
Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
Confidence82·developingImportance88NP-EVT-20261029-54DE649
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
Read the original at the primary source
Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
10/29/2026, 11:08:18 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indias · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —